Abstract
Diseases caused by pathogenic microorganisms in Bombyx mori have long been a major constraint on the sustainable development of sericulture. Current preventive strategies remain substantially constrained by issues of drug resistance and environmental compatibility. In recent years, the application of nanomaterials for pathogenic microorganism control has garnered escalating attention. Among these, chitosan-silver nanoparticles (CS-Ag NPs), as an emerging class of nanocomposites, integrate the biocompatibility and biodegradability of chitosan with the robust antimicrobial activity of silver nanoparticles, thereby exhibiting considerable potential for preventing pathogenic infections. Nevertheless, the efficacy of CS-Ag NPs against B. mori pathogens has not previously been documented. In this study, CS-Ag NPs were successfully synthesized via chemical reduction. Their antiviral activity was validated using quantitative PCR. The inhibitory efficacy of CS-Ag NPs against Bacillus bombysepticus and Serratia marcescens was evaluated through in vitro inhibition zone assays and bacterial growth curve analysis, with the minimum inhibitory (MIC) concentration for both pathogens determined. Notably, CS-Ag NPs exhibited no significant inhibitory effect on filamentous fungi, potentially due to the impaired ability of nanoparticles to penetrate fungal cell walls. Preliminary mechanistic investigations into the antimicrobial mechanism of CS-Ag NPs were conducted from the perspectives of oxidative stress. Our data showed that CS-Ag NPs could effectively alleviate ROS accumulation induced by the pathogen. In summary, our work systematically investigates the potential of CS-Ag NPs in controlling pathogens and enables the preliminary elucidation of their antibacterial mechanisms. These findings establish a theoretical foundation for the development of pharmaceuticals against pathogenic microorganisms and also offer novel insights into the ecofriendly management of diseases.